Rationale: The number of obese older adults with diabetes type 2 is increasing worldwide. Weight loss treatment in this group seems beneficial for cardio-metabolic and other health outcomes, but it might reduce muscle mass and bone mineral density (BMD). The association between obesity and BMD is controversial, and the role of muscle mass and dietary protein intake is not fully clear. This study explores the association between body weight, muscle mass, dietary protein intake, and physical activity level on BMD in obese older adults with diabetes type 2. Methods: For this cross-sectional analysis we used baseline data of a 13-week randomized trial evaluating the effect of a multi-modal intervention on muscle preservation and insulin sensitivity during a weight loss program in obese older adults (55-80y) with diabetes type 2 (PROBE). Body weight was measured using a calibrated scale (Life Measurement), appendicular lean mass (ALM) was used as a proxy for muscle mass and was measured by dual-energy X-ray absorptiometry (DXA, Hologic Discovery A), dietary protein intake was estimated by a 3-day food record, Physical Activity Level (PAL) was estimated by a 3-day activity record, and hip BMD was assessed by DXA. After determination of Pearson’s correlation coefficients for body weight, ALM, protein intake, and PAL with BMD, linear regression analysis was performed with significantly correlating determinants (body weight [kg], ALM [kg], protein intake [g/kg/d], and/or PAL [-]) and hip BMD (g/cm2) as outcome variable. Results: Mean age of the 122 included subjects was 67±6y, with a BMI of 33±4kg/m2. 65% of subjects were male. Body weight and ALM correlated significantly with BMD (r=0.34, p<0.001; r=0.43, p<0.001) whereas protein intake and PAL did not (r=0.02, p=0.84; r=0.005, p=0.95). Linear regression analysis with the two determinants body weight and ALM identified ALM as being significantly associated with BMD, whereas body weight was not. Beta for ALM was +0.011 g/cm2 (95% CI: 0.004 – 0.017; p<0.01), meaning that a 1 kg increase in ALM is associated with a +0.011 g/cm2 increase in BMD. Conclusion: In this explorative cross-sectional analysis appendicular muscle mass is positively associated with BMD, rather than body weight, protein intake, and physical activity level.
Rationale: Sarcopenia and obesity are prevalent conditions and are both associated with negative health outcomes. ESPEN and EASO reached consensus on the definition and diagnostic criteria for sarcopenic obesity (SO) encompassing indicators fat mass, muscle mass, and muscle function. However, few studies report on the effect of lifestyle interventions on these SO indicators. This study aimed to evaluate the effect of combined lifestyle interventions on SO indicators and on a composite SO index.Methods: Analyses were performed on two pooled RCT’s (MPS, PROBE) in older adults with obesity participating in a 13-wk program targeting weight loss while preserving muscle mass, providing a combination of caloric restriction, higher protein intake and resistance exercise training. SO indicators measured at baseline and post-intervention included 5x chair stand test (CST) in seconds for muscle function, fat mass percentage (FM%) and appendicular lean mass divided by body weight (ALM/W) using DXA. The SO index was calculated using sex-specific z-scores: -CST(s) + ALM/W – FM%; higher scores indicating better muscle function and body composition. Mixed model analyses were performed to assess the changes from baseline to post-intervention, adjusted for sex and age.Results: A total of 154 participants (age 65±6y; 59% male, BMI 33.1±4.3kg/m2) were included. After the 13-wk lifestyle interventions, weight (-2.87kg 95%CI -4.16;-1.64) and FM% (-1.81% 95%CI -2.42;-1.21) decreased significantly, CST improved significantly (-1.51s 95%CI -2.02;-1.00) from baseline and ALM/W was maintained (0kg/kg 95%CI 0.01;0.01). The SO index improved (+1.16 z-score 95%CI 0.86;1.44).Conclusion: Lifestyle interventions combining nutrition & exercise improved individual SO indicators and the SO index in older adults with obesity. The SO index could be a useful and sensitive criterion in the prevention and management of sarcopenic obesity.
Background: Weight loss is key to treatment of older adults with obesity and type 2 diabetes, but also a risk for muscle mass loss. This study investigated whether a whey protein drink enriched with leucine and vitamin D could preserve muscle mass and improve glycemic control during combined lifestyle intervention in this population. Methods: 123 older adults with obesity and type 2 diabetes were randomized into a 13-week lifestyle intervention with dietary advice and exercise, receiving either the enriched protein drink (test) or an isocaloric control (control). Muscle mass was assessed with dual-energy X-ray absorptiometry and glycemic control by oral glucose tolerance test. Statistical analyses were performed using a linear mixed model. Results: There was a nonsignificant increase in leg muscle mass (+0.28 kg; 95% CI, −0.01 to 0.56) and a significant increase in appendicular muscle mass (+0.36 kg; 95% CI, 0.005 to 0.71) and total lean mass (+0.92 kg; 95% CI, 0.19 to 1.65) in test vs. control. Insulin sensitivity (Matsuda index) also increased in test vs. control (+0.52; 95% CI, 0.07 to 0.97). Conclusions: Use of an enriched protein drink during combined lifestyle intervention shows beneficial effects on muscle mass and glycemic control in older adults with obesity and type 2 diabetes.
Het aantal migrantenouderen neemt sterk toe. Zij hebben een slechtere gezondheid dan autochtone ouderen. Zo komen chronische ziekten zoals obesitas en diabetes type 2 vaker voor. Een van de belangrijkste onderliggende oorzaken van deze ziekten is sarcopenie, verlies van spiermassa en fysiek functioneren van ouderen. Te weinig bewegen en een inadequate eiwitinname spelen een essentiële rol bij sarcopenie en daarbij ook bij chronische ziekten. Inzicht in sarcopenie, het beweegpatroon en de eiwitinname van migrantenouderen zijn onvoldoende beschikbaar. MKB-praktijken voor fysiotherapie en diëtetiek zien businesskansen om specifiek voor deze sterk groeiende doelgroep expertise op te bouwen en daarmee een groot aantal klanten te kunnen bedienen en te behouden. Het ontbreekt de praktijken echter aan de nieuwste kennis en inzichten voor een effectieve behandeling van sarcopenie bij migrantenouderen. Er zijn geen behandelprogramma’s beschikbaar die zij kunnen gebruiken. Daarnaast ondervinden zij met deze doelgroep problemen met de taal, opleidingsniveau en cultuurverschillen. Voor deze vraag van de MKB-praktijken wordt een beweeg- en voeding programma ontwikkeld speciaal gericht op de behoeften van migrantenouderen, fysiotherapeuten en diëtisten. Middels focusgroepen worden de behoeften van professionals en migrantenouderen onderzocht en voorspellers van beweeg- en voedinggedrag in kaart gebracht. Tevens wordt het fysiek functioneren, lichaams-samenstelling, beweeg- en voedingspatroon van verschillende migrantenouderen populaties geanalyseerd. Gebaseerd op deze uitkomsten wordt een nieuw beweeg en voedingsprogramma ontwikkeld om spiermassa en het fysiek functioneren van migrantenouderen te verbeteren (ProMIO programma). Hiervoor kunnen we gebruik maken van het ProMuscle programma, een succesvol voedings- en beweegprogramma voor sarcopenie uitkomsten voor ouderen. Middels een pilot studie wordt het ProMIO programma in de praktijk geëvalueerd op proces, haalbaarheid en bruikbaarheid voor de professional en migrantenouderen en wordt de effectiviteit op sarcopenie uitkomsten getoetst. De resultaten zullen worden gecommuniceerd naar de beroepenvelden en worden ingebed in het HBO-onderwijs.
The admission of patients to intensive care units (ICU) is sometimes planned after a large operation. However, most admissions are acute, because of life-threatening infections or trauma as a result of accidents. Their stay can last from a couple of days to a couple of weeks. ICU patients are often in pain, in fragile health condition, and connected to various devices such as a ventilator, intravenous drip, and monitoring equipment. The resulting lack of mobilization, makes patients lose 1-3% of muscle power for each day they are in the ICU. Within 2 weeks, patients can lose up to 50% of their muscle mass. Early mobilization of ICU patients reduces their time on a respirator and their hospital length of stay. Because of this, ICUs have started early mobilization physical therapy. However, there is a lack of solutions for patients that properly handle fear of movement, are sufficiently personalized to the possibilities and needs of the individual and motivate recurring use in this context. Meanwhile, various technological advances enable new solutions that might bring benefits for this specific use case. Hospitals are experimenting with screens and projections on walls and ceilings to improve their patients’ stay. Standalone virtual reality and mixed reality headsets have become affordable, available and easy to use. In this project, we want to investigate: How can XR-technologies help long-stay ICU patients with early mobilization, with specific attention to the issues of fear of movement, personalization to the individual’s possibilities, needs and compliance over multiple sessions? The research will be carried out in co-creation with the target group and will consist of a state-of-the-art literature review and an explorative study.
